Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling.

Precision disease modeling continues to mature in the academic space, but end-use by pharmaceutical companies is currently limited. To fully realize their transformative potential, OoC systems must balance their complexity with their ability to integrate with the highly standardized and high-throughput experimentation required for drug discovery and development.